Boehringer Ingelheim today announced the launch of its new direct-to-consumer platform, “Boehringer Ingelheim Access.” The platform will offer a convenient way for patients in the U.S. to order and ...

Lupin has signed a license and supply agreement with Sino Universal Pharmaceuticals for the commercialization of tiotropium dry powder inhaler, 18 mcg/capsule, in the Chinese market, for the treatment ...

Lupin has signed a license and supply agreement with Sino Universal Pharmaceuticals (SUP) for commercialisation of chronic obstructive pulmonary disease drug Tiotropium Dry Powder Inhaler, 18 ...

Global pharma major Lupin Limited (Lupin) announced that it has signed a license and supply agreement with Sino Universal Pharmaceuticals (SUP), for the commercialization of tiotropium dry powder ...

This partnership marks a strategic step for Lupin to tap into the burgeoning Chinese pharmaceutical market, particularly in the respiratory segment. Tiotropium DPI is a well-established medication ...

Drugmaker Lupin Ltd has signed a license and supply agreement with Sino Universal Pharmaceuticals (SUP), for the commercialisation of Tiotropium Dry Powder Inhaler (DPI) in China, for the treatment of ...

"Clinicians should carefully weigh the risks and benefits of various treatment options for COPD patients, considering both pulmonary and cardiovascular considerations."— Mario Cazzola, MD, Unit of ...

QUEBEC CITY, July 11, 2023 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) announced on May 26, 2023, that its Canada subsidiary, Lupin Pharma Canada Ltd., has received approval from Health ...

Lupin is partnering with Mark Cuban Cost Plus Drug Company and the COPD Foundation, in an effort to bolster access to health care by expanding the availability of Tiotropium Bromide Inhalation Powder, ...

Indian pharmaceutical major Lupin on September 6 announced it has tied up with American businessman Mark Cuban's Cost Plus Drugs and Florida-based non-profit COPD Foundation to expand medication ...

Mark Cuban Cost Plus Drug Company (MCCPDC) is partnering with multinational pharmaceutical company Lupin Limited and the COPD Foundation to expand access to Tiotropium Bromide Inhalation Powder for ...

Tiotropium (as bromide monohydrate) 18 micrograms powder for inhalation in capsules for use with LupinHaler is indicated for the long-term maintenance treatment of bronchospasm and dyspnea associated ...